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1. Introduction
The term ‘white dot syndromes’ (WDS) refers to several inflammatory diseases of the retina
and choroid caused by immune dysregulation. They consist of the following disorders, with
overlapping clinical features:
• Acute posterior multifocal placoid pigment epitheliopathy (APMPPE)
• Serpiginous choroidopathy
• Multiple evanescent white dot syndrome (MEWDS)
• Birdshot retinochoroidopathy
• Acute retinal pigment epitheliitis (ARPE)
• Multifocal choroiditis and panuveitis syndrome (MCP)
• Punctuate inner choroidopathy (PIC), and
• Acute zonal occult outer retinopathy (AZOOR)
These conditions usually occur following an influenza-like illness, but their patho-physiologic
mechanism remains poorly understood. The white dot syndromes affect more frequently
young females and individuals with mild myopia, and present as white or yellow, deep, round
lesions in the central fundus. Their size and number can vary between each entity, as well as
their uni- or bilateral involvement.
© 2013 Wolff et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
In addition to these clinical parameters, fluorescein (FA) and indocyanine green angiographies
(ICGA) help in identifying the diagnosis [1]. They also help assess the level of inflammatory
activity and detect complications.
The high resolution of the scans generated by Spectral Domain Optical Coherence Tomogra‐
phy (SD-OCT) offers a helpful tool in the management of WDS. SD-OCT allows a direct, non-
contact visualization of involved retinal layers and thereby provides information concerning
the:
• accurate location of the inflammatory process
• integrity of the photoreceptors inner segment / outer segment junction (IS/OS)
• course of the inflammatory process, leading to resolution or residual scarring
• presence of complications such as neovascularization
Moreover, the use of ‘en-face’ OCT for WDS allows a layer-by-layer view of the involved retina.
This novel imaging technique generates frontal scans derived from SD-OCT.
The scans of "en face" OCT imaging of WDS were obtained by Spectral-domain OCT (Spec‐
tralis® Heidelberg Engineering, Heidelberg, Germany). For every case, the macula was
analyzed using SD-OCT (Spectralis® Heidelberg Engineering, Heidelberg, Germany) and
macular mapping consisting of 197 transverse sections in a 5.79 x 5.79 mm2 central retinal area.
Tridimensional reconstruction generated by the pooling of these sections provides a virtual
macular brick, through which 496 shifting sections in the coronal plane result in the C-scan,
or “en face” OCT.
In contrast, B-scans for conventional OCT are derived from sagittal and transverse sections.
Enhanced depth imaging OCT (EDI-OCT) is a new tool that improves the sensitivity of the
imaging in deeper layers of retinal tissue. The visualization of the choroid is increased and
thus the obtained measurements are more accurate.
For each condition belonging to the WDS, we compared the results from SD-OCT “B-scan”
and ‘en-face’ with data from classical retinal imaging, namely fundus photography and
angiography.
2. MEWDS, Multiple evanescent white dot syndrome (figure 1)
MEWDS typically affects young females, and presents as a sudden visual loss with paracentral
scotomas. In 80% of cases the condition remains unilateral. Fundus examination reveals small,
discrete perifoveolar dots, very mild vitritis, and, in some cases, papillitis. On fluorescein
angiography these dots appear hyperfluorescent, but are hypofluorescent on ICGA. The
natural history leads usually to complete and spontaneous resolution within weeks.
• SD-OCT at the acute stage identifies the lesions in the outer retina as hyperreflective
thickened lesions of the inner segment/outer segment (IS/OS) junction, alternating with
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disruption of the IS/OS junction [2]. Small highly reflective dots involving the RPE inner
layer, the IS/OS junction and the outer nuclear layer can be observed. EDI-OCT frequently
demonstrates choroidal thickening.
• ‘En-face’ OCT shows multifocal involvement in the plane of the IS-OS junction, consisting
of various round hyporeflective lesions alternating with large hyperreflective areas.
Centrally, they may appear as confluent, which explains the “moth-eaten” appearance of
the macula in some cases. Hypofluorescent spots on ICGA and IS-OS disruption zones on
‘en-face’ OCT are well correlated [3]. This correlation is also observed between SD-OCT B-
scans and ICGA.
During follow-up, a progressive and complete restitution of outer retinal layers is observed.
This observation is correlated with functional resolution [4]. However, focal gaps in IS/OS
junction may persist in some cases and are associated with central visual field defects.
3. Acute posterior multifocal placoid pigment epitheliopathy (APMPPE)
(figure 2 and 3)
In this bilateral, often asymmetrical condition, that presents in healthy young adults, with both
male and female being affected equally, fundus examination reveals yellowish-white plaques
of 1 to 2 disc diameters, scattered from the fovea to the equator [5]. They may be associated
with mild vitritis. Their FA appearance in the acute stage is pathognomonic: early blockade
hypofluorescence, followed by late hyperfluorescence caused by staining. ICGA shows
multiple lesions that may be confluent, and that remain hypofluorescent during all angio‐
graphic stages.
In the acute stage, SD-OCT shows:
• On B-scan: hyperreflective lesions in outer retinal layers, some extending to Henle’s fibers
layer. Irregularities in IS/OS, external limiting membrane, and inner pigment epithelium
layer are also visible around those highly reflective lesions [6]. In the acute phase, an
elevation of the IS/OS junction with subretinal fluid located between this layer and the RPE
may be observed. In severe cases, this hyporeflective space between the IS/OS and external
limiting membrane can mimic an encapsulated serous retinal detachment. Hyperreflective
intrachoroidal spots are seen on EDI mode, suggesting choroidal inflammation.
• On ‘en-face’ OCT: the extent of the selesions, located in the external nuclear layer, are well
defined. These lesions perfectly match the hypofluorescent plaques seen on ICGA. In severe
cases with encapsulated serous retinal detachment, ‘en-face’ OCT reveals a wide hypore‐
flective lesion with hyperreflective borders. These large hyporeflective lesions may contain
tiny reflective deposits.
In the late stages, SD-OCT shows:
• On B-scans: retinal thinning with disruption of the IS/OS and inner pigment epithelium,
located where hyperreflective lesions had been observed. Irregular or focal gaps in external
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 Figure 1. MEWDS.a) MEWD acute phase: color fundus photography. Unilateral (Left eye) discrete perifoveal dots
(white arrow) with light papillitis(black arrow), b) MEWDS acute phase: SD-OCT B-scan. Visualization of large IS/OS
segment disruptions (black arrow) in the posterior pole, mostly in the foveal region, alternating with few focal, highly
hyperreflective, thickened IS/OS zones (orange arrows). c) MEWDS acute phase: SD-OCT B-scan. Tiny hyperreflective
elevations (spicules) (yellow arrows) visible in the areas with IS/OS disruption. Note the significant choroidal thicken‐
ing (blue arrow).d) MEWDS acute phase: En Face OCT. Multifocal involvement in the plane of the IS-OS junction, con‐
sisting of various round or oval coalescing hyporeflective lesions (black arrows) corresponding to areas of disrupted
IS/OS junctions seen on B-scans, alternating with large hyperreflective areas (orange arrows). The « spicules » are im‐
aged as very small hyperreflective spots (yellow arrows) within the hyporeflective zones of IS/OS junction disruptions.
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 Figure 2. AMPPE.(a-e). AMPPE early phase: a: AMPPE typical presentation with yellowish-white plaques of 1 to 2 disc
diameters, scattered from the fovea to the equator on color fundus photography. FA appearance in the acute phase is
pathognomonic with early blockade hypofluorescence, (figure 2b)followed by late hyperfluorescence phase (figure
2c). ICGA shows multiple lesions that may be confluent, and that remain hypofluorescent during all angiographic
phases (early phase: figure 2d) and late phase (figure 2e). f) AMPPE early phase: SD-OCT B-scan both images. Top: Hy‐
perreflective lesions in the outer retinal layers, some extending to Henle’s fibers layer. Irregularities in the IS/OS, exter‐
nal limiting membrane, and inner pigment epithelium layer are seen around the hyperreflective lesions (white
arrows). Bottom: En face OCT. Left: Visualization of the hyporeflective lesions corresponding to the alterations in the
IS/OS junction (yellow arrows). Right: Hyperreflective band within the outer nuclear layer (orange arrows) surround‐
ing the hyporeflective lesions (corresponding to hypofluorescent spots on ICGA).g) AMPPE late phase.Left: SD-OCT B-
scan. Areas of irregularly thickened pigment epithelium (orange arrow). Right: En face OCT. These irregularly
thickened areas of pigment epithelium are visualized as hyperreflective zones (orange arrows).Hyporeflective areas
are due to previous IS/OS junction involvement (yellow arrows).
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 Figure 3. AMPPE.a) AMPPE early phase of a more severe case. Autofluorescence images: Irregular autofluorescent
areas in both eyes (white arrows). b) AMPPE early phase, left eye. Left: SD-OCT B-scan. Hyperreflective lesions (yellow
arrows) in the outer retinal layers, extending to Henle’s fibers layer. Irregularities in the IS/OS, external limiting mem‐
brane, and inner pigment epithelium layers are visible around the highly reflective lesions. Subretinal fluid is observed
located between the IS/OS junction and the RPE (pink arrow) as well as hyperreflective small spots within the choroid
(blue arrows). Right: En face OCT. Round or oval coalescing moderately reflective lesions (yellow arrow head) bor‐
dered by a hyporeflective band (black arrows) located inside a hyperreflective area (pink arrow head). c) AMPPE late
phase. Left: SD-OCT B-scan. Thinned IS/OS junction areas and RPE irregularities (green arrows) Right: En face OCT.
Global improvement at the IS/OS junction plane with scarring represented by hyper- (pink arrows) and hyporeflective
areas (black arrows) d) AMPPE early phase. Left: SD-OCT B-scan. Severe alterations of the whole outer retina (pink ar‐
rows) with IS/OS segment disruption (yellow arrow) and hyperreflective spots within the choroid (blue arrow). Right:
En face OCT. Scan at the level of IS/OS segment plane: extensive hyporeflective lesions (yellow arrow head) corre‐
sponding to IS/OS segment disruption. e). AMPPE late phase. Left: SD-OCT B-scan. Outer retinal scar represented by
alternation of thinning (green arrow) and thickening (white arrow) of the IS/OS and RPE tissues. Right: En face OCT.
Global improvement at the IS/OS plane with the association of hyperreflective (white arrows) and hyporeflective areas
(black arrow) of the scarring process in the IS/OS and RPE complex.
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limiting membrane can also occur [7]. In some cases, complete resolution of outer retinal
defects may be seen. Classically, involvement of the pigment epithelium has been described
[8]. It appears in the late stage as areas of irregular, thickened pigment epithelium.
• ‘En-face’ OCT demonstrates a decrease in the highly reflective lesions that are replaced with
hyporeflective areas due to IS/OS junction involvement. Hyperreflective dots corresponding
to focal areas of thickened RPE can be observed inside this hyporeflective IS/OS junction layer.
4. Serpiginous choroiditis (figure 4)
This chronic, progressive, bilateral and asymmetrical condition presents equally in men and
women, from the 2nd to the 6th decade of life [9]. Various infectious etiologies have been
suggested, among which tuberculosis must be formally ruled out [10]. Clinical and angio‐
graphic examination identifies greyish-white digitations starting from the optic disc. Its active
border appears hypofluorescent on FA. ICGA is a useful tool for evaluating the response to
treatment, since lesions are more extended on ICGA than on FA.
• On SD-OCT, in the active phase, hyperreflective lesions in the outer retinal layers can be
observed, some extending to Henle’s fibers layer. In the late stage, areas of irregular,
thickened pigment epithelium are seen regarding a loss of structure in the external layers
(IS/OS, Verhoeff’s membrane) [11]. Many hyperreflective dots are present inside the
choroid. Choroidal thickening is also seen on EDI.
• ‘En-face’ OCT confirms that the appearance of the network of digitations is due to outer
retinal changes [12]. Active lesions are observed at the level of the ONL as branching mildly
reflective lesions. In the late stage, hyperreflective digitations are seen at the level of the RPE
and correspond to areas of thickened RPE.
5. Punctuate inner choroiditis (PIC) and multifocal choroiditis and
panuveitis (MCP) (figure 5)
These two conditions share common characteristics: small, sharp lesions that evolve rapidly
towards pigmented scars, affecting myopic females between 20 and 40 years of age. PIC differs
from MCP by the absence of vitritis and the limitation of the lesions to the posterior fundus,
while they can extend to the equatorial fundus in MCP [13]. FA is marked by a late hyper‐
fluorescence. From mid-sequence on ICGA, the lesions appear hypofluorescent, and more
numerous than on funduscopy.
• With SD-OCT, sections through a lesion show accumulation of drusenoid deposits between
the pigment epithelium and Bruch’s membrane [14]. Disruption of the IS/OS junction and
RPE may be observed on the top of these elevations.
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 Figure 4. SERPIGINOUS CHOROIDITIS. a) Serpiginous choroiditis acute phase: ICGA. Hypo fluorescent digitations start‐
ing from the optic disc (pink arrows). b) Serpiginous choroiditis acute phase: SD-OCT (top and down) Hyperreflective le‐
sions in the outer retinal layers, some extending to Henle’s fibers layer (yellow arrows). Numerous hyperreflective dots are
present inside the choroid (green arrows). Choroidal thickening is seen on EDI (white double head arrow). c) Serpiginous
choroiditis acute phase: Active lesions are observed at the level of the ONL (left) and IS/OS junction layer (right) as branch‐
ing mildly reflective lesions (yellow arrows). d) Serpiginous choroiditis late phase: in the late stage, hyperreflective digita‐
tions are seen at the level of the RPE and correspond to areas of thickened RPE (blue arrows).
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 Figure 5. CMF.a) CMF acute phase: SD-OCT B-scan. Presence of deposits between the Brüch’s membrane and RPE
looking like fusiform, hyperreflective, small, dome shape elevations of the RPE (green arrows). An interruption of the
IS/OS junction at the top of the dome shape elevation is also seen (pink arrow) b) CMF late phase: SD-OCT B-scan, Post
treatment: the RPE elevation slowly and progressively decreases after treatment (green arrow) with the disappearance
of the interruptions in the IS/OS junction (pink arrow). c) CMF acute phase: En Face OCT. Multiple, small, round or oval
shaped hyperreflective lesions are seen in front of the RPE layer with a well defined hyporeflective centre and borders
(black arrows).In the fovea, the hyperreflective CNV scar (with a hyperreflective border) is fibrous but still active (white
arrow) with a hyporeflective area all around the scar corresponding to a serous retinal detachment(yellow arrow). d)
CMF late phase: En Face OCT. Progressive disappearance of the outer retinal lesions which are faintly hyporeflective
(black arrows). However, the CNV is still active (yellow arrow) e). Differentiation between CNV and choroiditis lesion.
En face OCT, before anti-VEGF treatment: the moderately hyperreflective CNV has irregular edges. It corresponds on
SD-OCT B-scan to the moderately hyperreflective pre- epithelial lesion associated with overlying retinal thickening. f).
Differentiation between CNV and choroiditis lesion. En face OCT, after anti-VEGF treatment: the borders of the CNV
become more hyperreflective and better defined.This corresponds on SD-OCT B-scan to an involuted CNV that has be‐
come more hyperreflective but still active (blurred limits in the superior part).
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• In the macular area, ‘en-face’ OCT shows the presence of multiple hyperreflective lesions
above the level of the pigment epithelium. These lesions often show mild central hypore‐
flectivity. Comparison of ‘en-face’ OCT with ICGA reveals that these highly reflective
lesions and hypofluorescent dots on ICGA closely match. This correlation is also observed
with SD-OCT B-scans.
During follow-up, these outer retinal lesions progressively regress on ‘en-face’ OCT, which
is usually associated with functional recovery.
Both PIC and MCP are at high risk of neovascular complications.
• When neovascularization occurs, a fusiform, hyperreflective thickening above the level of
the pigment epithelium is seen on SD-OCT B-scans, and is usually associated with intrare‐
tinal cystoid exudative cavities [15].
• ‘En-face’ OCT imaging of this lesion, above the level of the pigment epithelium, reveals its
irregular borders, thus distinguishing it from inflammatory lesions. ‘En-face’ OCT also
allows analysis of all exudative cavities in one section, which is helpful for an improved,
comparative follow-up.
This neovascularization can regress after repeated intravitreal anti-VEGF injections, provid‐
ing that inflammation is sufficiently controlled.
6. Birdshot chorioretinopathy (figure 6)
Birdshot chorioretinopathy is a slowly progressing, bilateral inflammation. It predominantly
affects women and appears between 30 and 70 (mean age: 53) years. Association with HLA
A29 is a common feature. Multiple hypopigmented choroidal lesions characterize the fun‐
dus [17]. FA is more useful in detecting complications (vasculitis, macular edema) than in
analyzing the dots, for which ICGA is preferred. Indeed, they appear hypopigmented and
often more numerous than on funduscopy.
• During active and severe phases, SD-OCT may identify drusenoid deposits between the
pigment epithelium and IS/OS junction with a posterior shadow inside the choroid.
Hyperreflective intraretinal dots, located in the outer nuclear layer (ONL) and correspond‐
ing to inflammatory deposits may be seen in acute phase. However, SD-OCT’s main
application for Birdshot chorioretinopathy is the screening for complications, mostly cystoid
macular edema [18] or epiretinal membrane [19]. In the late phase, cases with poor control
of inflammation (due to insufficient treatment or lack of response to appropriate therapy)
evolve towards outer retinal atrophy, with IS/OS disruptions. SD-OCT is then an efficient
tool to distinguish between these various causes of visual loss, and leads to appropriate
treatment when needed [20].
• On ‘en face‘ OCT, a hyperreflective border stretching along the retinal vessels and corre‐
sponding to vasculitis can be observed. Multiple hyperreflective dots can be seen inside the
ONL. In acute and severe phases, mildly reflective lesions located above the RPE layer can









Figure 6. Birdshot chorioretinopathy. a) Birdshot chorioretinopathy, active phase: marked retinal vasculitis observed
on FA with dye leakage at the level of the vascular wall (blue arrows). b) Birdshot chorioretinopathy, active phase. IC‐
GA: numerous hypofluorescent spots are visible scattered in the posterior pole and nasal to the optic nerve during all
the angiography sequences (Yellow arrow). c) Birdshot chorioretinopathy, active phase. SD-OCT B-scan: small hyperre‐
flective lesions (white arrows) are seen located inside the RPE behind the IS/OS and leading to a shadow cone (green
arrow) at the choroidal level (drusenoid like deposits). d) En face OCT: Birdshot chorioretinopathy, severe clinical
forms. Multiple hypermoderately hyperreflective spots are observed between the RPE and the IS/OS junction (blue ar‐
rows). e) Birdshot chorioretinopathy, active phase. En face OCT: small multiple hyperreflective spots are visualized in
the outer nuclear layer (blue arrows). Corresponding b-scan in the bottom. f) Birdshot chorioretinopathy, active phase.
Top: FA of a patient with moderate vasculitis. Bottom: « en face » OCT improves the visualization of vasculitis by the
hyperreflective sheathing of the vascular wall (pink arrow).
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 Figure 7. ARPE. a) ARPE acute phase: Yellowish halo around the fovea on color fundus photography. b and c. ARPE
acute phase, horizontal and vertical SD-OCT B-scan crossing the fovea: disruption of both the internal RPE layer and
IS/OS junction in the fovea (black arrows). Small hyperreflective foveal deposits (yellow arrow) are seen at the level of
the internal nuclear layer. A faint hyperreflective IS/OS segment thickening is visualized around the central disruption
(white arrows). d) ARPE early phase. Late phase ICGA shows mild hyperreflective halo (cockade shape) in the fovea. e).
ARPE early phase, En face OCT: scan at the IS/OS junction plane. Hyperreflective halo (cockade shape) is visualized sur‐
rounding the fovea that appears hyporeflective (orange arrow). The halo corresponds to the faint hyperreflective
thickening of the IS/OS junction around the hyporeflective central zone corresponding to the central IS/OS junction
disruption (black arrow). f) ARPE early phase, En face OCT. Punctuate hyperreflective foveolar spots corresponding to
the central deposits found in the acute phase at the outer nuclear layer level (yellow arrow).g) ARPE late phase, SD-
OCT B-scan (top) and En face OCT (down): return to normality with incomplete recovery of the central IS/OS junction
disruption.
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7. Acute retinal pigment epitheliitis (ARPE) (figure 7)
ARPE, or Krill’s disease, named after its first description by Krill in 1974 [21], is a benign, self-
limited, bilateral yet asymmetrical condition affecting adults between 10 and 40 years of age.
Funduscopy identifies a yellowish halo around the fovea, without vitritis. ICGA is crucial to
rule out a MEWDS that may have a similar presentation. It shows a typical, sharply demar‐
cated, round, macular area [22].
• A subfoveal involvement with blurring of the inner pigment epithelium and IS/OS junction
is visible on SD-OCT. Small hyperreflective deposits between the IS/OS junction and outer
nuclear layer are identified in some cases. Around this disrupted foveal area, one can
frequently observe IS/OS junction thickening.
• The extent of outer retinal damage, mainly at IS/OS level, is evidenced by ‘en-face’ OCT.
The central lesion demonstrates a cockade-like appearance with a hyporeflective center and
a hyperreflective border. This cockade appearance matches the pattern observed on ICGA.
Punctuate, highly reflective, subfoveolar lesions, resolving within days, can also be ob‐
served. During follow-up, full resolution of all the abnormal findings occurs without
treatment [22].
8. Conclusion
White dots syndromes refer to several disease that evolve quickly. Retinal and choroidal
involvement  follows  different  phases:  invasive  phase,  intermediate  phase  and  chronic
phase.  Retinal  and  choroidal  changes  observed  with  multimodal  imaging  are  transient
and may disappear  quickly  in  some cases.  All  these  entities  probably  share  a  common
pathway leading to external  retinal  involvement.  ‘En face’  OCT imaging enables the as‐
sessment of the extent of structural damage occurring in WDS. OCT with “en face” OCT
enhances its sensitivity, allowing earlier diagnosis of retinal changes and a more reliable
follow-up. Further prospective studies including more patients will  be necessary to con‐
firm these results.
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